Cargando…
Ischemic stroke risk estimation in patients without oral anticoagulation: an observational cohort study based on secondary data from Germany
BACKGROUND: Oral anticoagulants can cause potentially serious adverse events. Therefore, before prescribing oral anticoagulants for ischemic stroke prevention in patients with atrial fibrillation (AF), stroke risk assessment is required to identify patients that are likely to benefit from treatment....
Autores principales: | Wicke, Felix S., Schaller, Martin A., Karymova, Kateryna, Beyer, Martin, Müller, Beate S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480434/ https://www.ncbi.nlm.nih.gov/pubmed/31014253 http://dx.doi.org/10.1186/s12872-019-1074-7 |
Ejemplares similares
-
SOP: thrombolysis in ischemic stroke under oral anticoagulation therapy
por: Kermer, Pawel, et al.
Publicado: (2022) -
Anticoagulation After Ischemic Stroke or Transient Ischemic Attack (TIA) in the Time of Direct Oral Anticoagulation (DOAC) and Thrombectomy
por: Martin Diaz, Claudia, et al.
Publicado: (2021) -
Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023) -
Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants
por: Luger, Sebastian, et al.
Publicado: (2015) -
Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation
por: Tiili, Paula, et al.
Publicado: (2021)